
    
      Prospective project in collecting and assessing clinical outcomes data related to molecular
      profiling of tumors based on cancer primary or metastatic tissue or tissue from peripheral
      blood samples. As a future part of the project will be collected patient reported outcomes
      (PROs) for assessing clinical outcomes in relation to clinical pathways, patient reported
      results, as well as tumor profiling by molecular methods.
    
  